Detalles de la búsqueda
1.
Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation.
Transplantation
; 75(1): 37-43, 2003 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12544868
2.
Improved rejection prophylaxis with an initially intensified dosing regimen of enteric-coated mycophenolate sodium in de novo renal transplant recipients.
Transplantation
; 92(3): 321-7, 2011 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21694664
3.
Evolution of the absorption profile of cyclosporine A in renal transplant recipients: a longitudinal study of the de novo and maintenance phases.
Nephrol Dial Transplant
; 21(1): 197-202, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16204301
4.
Safety and efficacy of an alternative basiliximab (Simulect) regimen after renal transplantation: administration of a single 40-mg dose on the first postoperative day in patients receiving triple therapy with azathioprine.
Transpl Int
; 16(1): 45-52, 2003 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-12545341
5.
Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients.
Liver Transpl
; 8(2): 123-31, 2002 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-11862588
Resultados
1 -
5
de 5
1
Próxima >
>>